172 related articles for article (PubMed ID: 22162176)
1. The limited screening value of insulin-like growth factor-I as a marker for alterations in body composition in very long-term adult survivors of childhood cancer.
Blijdorp K; van den Heuvel-Eibrink M; Pieters R; Boot A; Sluimer J; van der Lelij AJ; Neggers S
Pediatr Blood Cancer; 2012 Oct; 59(4):711-6. PubMed ID: 22162176
[TBL] [Abstract][Full Text] [Related]
2. Survivors of childhood acute lymphoblastic leukaemia, with radiation-induced GH deficiency, exhibit hyperleptinaemia and impaired insulin sensitivity, unaffected by 12 months of GH treatment.
Bülow B; Link K; Ahrén B; Nilsson AS; Erfurth EM
Clin Endocrinol (Oxf); 2004 Dec; 61(6):683-91. PubMed ID: 15579181
[TBL] [Abstract][Full Text] [Related]
3. Cranially irradiated adult cancer survivors may have normal spontaneous GH secretion in the presence of discordant peak GH responses to stimulation tests (compensated GH deficiency).
Darzy KH; Thorner MO; Shalet SM
Clin Endocrinol (Oxf); 2009 Feb; 70(2):287-93. PubMed ID: 18673465
[TBL] [Abstract][Full Text] [Related]
4. No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemia.
van Beek RD; de Muinck Keizer-Schrama SM; Hakvoort-Cammel FG; van der Sluis IM; Krenning EP; Pieters R; van den Heuvel-Eibrink MM
Pediatr Blood Cancer; 2006 Jan; 46(1):88-93. PubMed ID: 15926166
[TBL] [Abstract][Full Text] [Related]
5. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
Högler W; Briody J; Moore B; Lu PW; Cowell CT
Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
[TBL] [Abstract][Full Text] [Related]
6. Determinants of IGF-I status in a large cohort of growth hormone-deficient (GHD) subjects: the role of timing of onset of GHD.
Lissett CA; Jönsson P; Monson JP; Shalet SM;
Clin Endocrinol (Oxf); 2003 Dec; 59(6):773-8. PubMed ID: 14974921
[TBL] [Abstract][Full Text] [Related]
7. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G
Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581
[TBL] [Abstract][Full Text] [Related]
8. Young adult survivors of childhood acute lymphoblastic leukemia: spontaneous GH secretion in relation to CNS radiation.
Jarfelt M; Bjarnason R; Lannering B
Pediatr Blood Cancer; 2004 Jun; 42(7):582-8. PubMed ID: 15127412
[TBL] [Abstract][Full Text] [Related]
9. Final height and weight of long-term survivors of childhood malignancies.
Müller HL; Klinkhammer-Schalke M; Kühl J
Exp Clin Endocrinol Diabetes; 1998; 106(2):135-9. PubMed ID: 9628245
[TBL] [Abstract][Full Text] [Related]
10. Effects of growth hormone therapy on bone mass, metabolic balance, and well-being in young adult survivors of childhood acute lymphoblastic leukemia.
van den Heijkant S; Hoorweg-Nijman G; Huisman J; Drent M; van der Pal H; Kaspers GJ; Delemarre-van de Waal H
J Pediatr Hematol Oncol; 2011 Aug; 33(6):e231-8. PubMed ID: 21792029
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukemia in childhood.
Link K; Moëll C; Garwicz S; Cavallin-Ståhl E; Björk J; Thilén U; Ahrén B; Erfurth EM
J Clin Endocrinol Metab; 2004 Oct; 89(10):5003-12. PubMed ID: 15472198
[TBL] [Abstract][Full Text] [Related]
12. Blood pressure and body composition in long-term survivors of childhood acute lymphoblastic leukemia.
Veringa SJ; van Dulmen-den Broeder E; Kaspers GJ; Veening MA
Pediatr Blood Cancer; 2012 Feb; 58(2):278-82. PubMed ID: 21793179
[TBL] [Abstract][Full Text] [Related]
13. Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial.
Willemsen RH; Arends NJ; Bakker-van Waarde WM; Jansen M; van Mil EG; Mulder J; Odink RJ; Reeser M; Rongen-Westerlaken C; Stokvis-Brantsma WH; Waelkens JJ; Hokken-Koelega AC
Clin Endocrinol (Oxf); 2007 Oct; 67(4):485-92. PubMed ID: 17561977
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone releasing hormone plus arginine stimulation testing in young adults treated in childhood with cranio-spinal radiation therapy.
Ham JN; Ginsberg JP; Hendell CD; Moshang T
Clin Endocrinol (Oxf); 2005 May; 62(5):628-32. PubMed ID: 15853837
[TBL] [Abstract][Full Text] [Related]
15. The influence of growth hormone replacement on peripheral inflammatory and cardiovascular risk markers in adults with severe growth hormone deficiency.
Deepak D; Daousi C; Javadpour M; Clark D; Perry Y; Pinkney J; Macfarlane IA
Growth Horm IGF Res; 2010 Jun; 20(3):220-5. PubMed ID: 20185347
[TBL] [Abstract][Full Text] [Related]
16. Body composition, IGF-I and IGFBP-3 concentrations as outcome measures in severely GH-deficient (GHD) patients after childhood GH treatment: a comparison with adult onset GHD patients.
Attanasio AF; Howell S; Bates PC; Frewer P; Chipman J; Blum WF; Shalet SM
J Clin Endocrinol Metab; 2002 Jul; 87(7):3368-72. PubMed ID: 12107251
[TBL] [Abstract][Full Text] [Related]
17. Growth, growth hormone and final height after BMT. Possible recovery of irradiation-induced growth hormone insufficiency.
Holm K; Nysom K; Rasmussen MH; Hertz H; Jacobsen N; Skakkebaek NE; Krabbe S; Müller J
Bone Marrow Transplant; 1996 Jul; 18(1):163-70. PubMed ID: 8832010
[TBL] [Abstract][Full Text] [Related]
18. Improvement in cardiac systolic function and reduced prevalence of metabolic syndrome after two years of growth hormone (GH) treatment in GH-deficient adult survivors of childhood-onset acute lymphoblastic leukemia.
Follin C; Thilén U; Ahrén B; Erfurth EM
J Clin Endocrinol Metab; 2006 May; 91(5):1872-5. PubMed ID: 16522695
[TBL] [Abstract][Full Text] [Related]
19. [A comparative study of the weight-height development of the long-term survivors of acute leukemia and solid tumors].
López Andreu JA; Albiach Mesado V; Ferrís i Tortajada J; Rodríguez Ineba A; Antonio Oriola P; Verdeguer Miralles A
An Esp Pediatr; 1999 Jun; 50(6):555-61. PubMed ID: 10410416
[TBL] [Abstract][Full Text] [Related]
20. The impact of idiopathic childhood-onset growth hormone deficiency (GHD) on bone mass in subjects without adult GHD.
Lange M; Müller J; Svendsen OL; Kastrup KW; Juul A; Feldt-Rasmussen U
Clin Endocrinol (Oxf); 2005 Jan; 62(1):18-23. PubMed ID: 15638865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
